Ahil Ganesh

Ahil Ganesh is a Lead Scientist in Delivery Platforms at Roche, where they focus on formulation development for controlled release, targeted delivery, and regenerative medicine. With a PhD in Chemical and Biomedical Engineering from the University of Toronto, Ahil has extensive experience across various modalities, including small molecules, proteins, and gene therapies. They have previously held roles as a Senior Research Scientist at Spark Therapeutics, Inc. and a Postdoctoral Research Associate at Novartis Institutes for BioMedical Research. Ahil is a skilled communicator and critical thinker, actively contributing to peer-reviewed publications and presenting at international conferences.